F2RL1 and Shock: The results of our study indicate that 1-Piperidin Propionic Acid reduces mortality and sepsis-related features in septic shock through the inhibition of protease-activated receptor 2, preventing the activation of pathways leading to cytokine release, hypercoagulable state, and vasodilation, which are the hallmarks of septic shock.